Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Sell
6,850
-119
-2% -$40.7K 0.11% 166
2026
Q1
$2.45M Sell
6,969
-90
-1% -$32.1K 0.12% 166
2025
Q4
$2.31M Sell
7,059
-625
-8% -$198K 0.11% 156
2025
Q3
$2.17M Sell
7,684
-884
-10% -$256K 0.13% 134
2025
Q2
$2.39M Sell
8,568
-2,099
-20% -$595K 0.22% 89
2025
Q1
$3.32M Buy
10,667
+919
+9% +$271K 0.2% 107
2024
Q4
$2.54M Buy
9,748
+385
+4% +$114K 0.16% 133
2024
Q3
$3.02M Sell
9,363
-852
-8% -$279K 0.21% 112
2024
Q2
$3.19M Sell
10,215
-1,028
-9% -$302K 0.24% 98
2024
Q1
$3.2M Buy
11,243
+87
+0.8% +$25.5K 0.25% 96
2023
Q4
$3.21M Sell
11,156
-659
-6% -$180K 0.27% 86
2023
Q3
$3.18M Buy
11,815
+1,288
+12% +$321K 0.33% 76
2023
Q2
$2.34M Buy
10,527
+2,259
+27% +$524K 0.29% 80
2023
Q1
$2M Buy
8,268
+1,178
+17% +$289K 0.33% 70
2022
Q4
$1.86M Buy
7,090
+528
+8% +$142K 0.34% 67
2022
Q3
$1.48M Buy
6,562
+633
+11% +$153K 0.36% 61
2022
Q2
$1.44M Buy
5,929
+70
+1% +$17.2K 0.32% 71
2022
Q1
$1.42M Buy
5,859
+49
+0.8% +$11.3K 0.29% 75
2021
Q4
$1.31M Buy
5,810
+918
+19% +$194K 0.28% 88
2021
Q3
$1.04M Buy
4,892
+3,517
+256% +$809K 0.27% 86
2021
Q2
$335K Buy
1,375
+126
+10% +$31K 0.09% 192
2021
Q1
$311K Buy
1,249
+109
+10% +$26K 0.14% 169
2020
Q4
$262K Buy
1,140
+16
+1% +$3.69K 0.13% 189
2020
Q3
$286K Buy
1,124
+131
+13% +$32.5K 0.16% 145
2020
Q2
$234K Buy
993
+433
+77% +$98.8K 0.12% 160
2020
Q1
$114K Hold
560
0.08% 226
2019
Q4
$135K Buy
+560
New +$123K 0.08% 223

Other funds holding AMGN

Procyon Advisors's AMGN Position: Q2 2026 in Review

Procyon Advisors reduced its Amgen (AMGN) stake by 1.7% in Q2 2026, selling an estimated $40.7K and leaving 6,850 shares worth $2.48M. The position accounts for 0.11% of the portfolio, ranked #166.

Procyon Advisors first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.32M in Q1 2025. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Procyon Advisors held 6,850 shares of Amgen worth $2.48M as of Q2 2026.
  • Procyon Advisors sold 119 Amgen shares in Q2 2026, an estimated $40.7K.
  • Amgen made up 0.11% of Procyon Advisors's portfolio in Q2 2026, its #166 holding.
  • Procyon Advisors first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • Procyon Advisors's Amgen position peaked at $3.32M in Q1 2025.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.